iOrganBio Appoints Neuron Expert Dr. Zhiping Pang to Advisory Board

iOrganBio, a pioneer in intelligent cell manufacturing, has appointed Zhiping Pang, M.D., Ph.D., to its Scientific Advisory Board. Dr. Pang is a renowned expert in human neuron biology, synaptic function, and the molecular mechanisms underlying neuropsychiatric and metabolic disorders, with over 140 publications in top journals like Nature and Science. He serves as the Henry Rutgers Professor of NeuroMetabolism and Professor of Neuroscience and Cell Biology at Rutgers Robert Wood Johnson Medical School, and Director of the Center for NeuroMetabolism at Rutgers Health. His addition bolsters iOrganBio's scientific breadth as the field shifts toward more human-relevant, non-animal systems, such as FDA-aligned New Approach Methodologies (NAMs). To view the full announcement, including downloadable images, bios, and more, click here.

iOrganBio is transforming human cell production with CellForge™, its AI-powered platform for consistent, scalable, and intelligent manufacturing of cells and organoids for in vitro modeling and cell therapies. By applying engineering precision to biology, CellForge uses AI and automation to guide cell development and make real-time adjustments aligned with defined biological profiles. At the core of the platform is iOrganBio's functional human CellAtlas™, a comprehensive reference built from single-cell and multi-omics data that provides the digital blueprints for each cell type. This smart, closed-loop process delivers the accuracy, efficiency, and quality partners need to turn scientific ideas into breakthroughs, accelerating disease modeling, regenerative medicine, and drug development. Dr. Pang's expertise in human neuron biology will be instrumental in advancing these capabilities, particularly for neuropsychiatric and metabolic disease research.

The appointment underscores iOrganBio's commitment to leading the charge in AI-enabled, scalable human cell and organoid production. As the industry moves away from animal models toward human-relevant systems, having top-tier scientific guidance is critical. Dr. Pang's deep knowledge of synaptic function and neuropsychiatric disorders will help iOrganBio refine its CellForge platform and CellAtlas reference to produce neurons and brain organoids that faithfully recapitulate human biology. This could significantly impact drug discovery for conditions like Alzheimer's, Parkinson's, and metabolic syndromes, where traditional models have fallen short. For more information, visit iOrgan.Bio or follow on LinkedIn.